LLY ELI LILLY & Co

NYSE lilly.com


$ 1,040.88 $ -6.31 (-0.6 %)    

Thursday, 20-Nov-2025 16:39:44 EST
QQQ $ 584.62 $ -14.20 (-2.37 %)
DIA $ 458.30 $ -3.66 (-0.79 %)
SPY $ 652.19 $ -10.10 (-1.52 %)
TLT $ 89.30 $ 0.35 (0.39 %)
GLD $ 375.00 $ -0.11 (-0.03 %)
$ 1043.29
$ 1,047.02
$ 1,042.67 x 46
$ 1,044.00 x 1
$ 1,038.25 - $ 1,057.00
$ 621.50 - $ 1,057.00
3,135,742
na
937.71B
$ 0.54
$ 50.93
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-19-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 10-27-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-17-2021 12-31-2020 10-K
21 10-28-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-01-2020 03-31-2020 10-Q
24 02-19-2020 12-31-2019 10-K
25 10-25-2019 09-30-2019 10-Q
26 08-02-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 07-25-2018 06-30-2018 10-Q
31 04-27-2018 03-31-2018 10-Q
32 02-20-2018 12-31-2017 10-K
33 10-27-2017 09-30-2017 10-Q
34 07-28-2017 06-30-2017 10-Q
35 05-01-2017 03-31-2017 10-Q
36 02-21-2017 12-31-2016 10-K
37 10-28-2016 09-30-2016 10-Q
38 07-28-2016 06-30-2016 10-Q
39 04-29-2016 03-31-2016 10-Q
40 02-19-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

$120 million industry investment will grow talent and innovation in Virginia's life sciences ecosystem.RICHMOND, Va., Nov. ...

 truist-securities-maintains-buy-on-eli-lilly-raises-price-target-to-1182

Truist Securities analyst Robyn Karnauskas maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1038 ...

 eli-lilly-expands-biotech-support-with-new-gateway-labs-hub-in-philadelphia-to-boost-startup-breakthroughs-in-gene-therapy-and-next-gen-medicines

Eli Lilly and Company (NYSE:LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing it...

 tech-stocks-drop-pharma-gains-as-sector-rotation-picks-up-whats-moving-markets-tuesday

Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New Y...

 jp-morgan-maintains-overweight-on-eli-lilly-raises-price-target-to-1150

JP Morgan analyst Chris Schott maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1050 to $1...

 oprah-winfrey-backed-wellness-stock-stumbles-as-glp-1-boom-reshapes-consumer-habits-growth-score-plummets

Prominent weight-loss and wellness company, WW International Inc. (NASDAQ: WW), backed by renowned talk show host Oprah Winfrey...

Core News & Articles

-Reuters 

 is-ai-the-key-to-beating-cancer-why-pharma-stocks-are-soaring

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

 hedge-funds-snap-up-eli-lilly-united-healthcare-and-more-putting-healthcare-etfs-back-in-the-spotlight

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensi...

 maplebear-tower-semiconductor-and-eli-lilly-are-among-the-top-10-large-cap-gainers-last-week-nov-10-nov-14-are-the-others-in-your-portfolio

Ten large-cap standouts—including Maplebear, Tower Semiconductor, Eli Lilly, On Holding, Albemarle, and key gold/silver miners—...

 eli-lilly-supremacy-how-one-stock-is-dictating-performance-across-pharma-etfs

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed t...

 druckenmiller-opens-position-in-amazon-closes-microsoft--heres-more-of-duquesnes-biggest-q3-moves

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven...

 government-reopens-ai-stocks-slide-on-supply-crunch-fears-this-week-in-markets

Markets digest U.S. government reopening, hawkish Fed outlook, and AI sell-off as CoreWeave crashes 25%.

 fear-of-an-ai-bubble-this-sector-is-quietly-surging-while-tech-sinks

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

 ozempic-maker-novo-nordisk-faces-board-shakeup

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION